Article
High-Potency Polypeptide-based Interference for Coronavirus Spike Glycoproteins
2021-04-05
Abstract excerpt
The world is experiencing an unprecedented coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 spike protein-based vaccines are currently the main preventive agent to fight against the virus. However, several variants with extensive mutations in SARS-CoV-2 spike proteins have emerged. Some of these variants exhibited increased replication,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e5996b21-636c-534b-a8ff-eaf55b4aaacc
- DOI
- 10.21203/rs.3.rs-388285/v1
